Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 1
1982 1
1983 2
1984 1
1985 1
1986 1
1987 1
1988 2
1989 2
1990 1
1991 1
1992 3
1993 2
1994 7
1995 3
1996 4
1997 3
1998 4
1999 5
2000 3
2001 2
2002 4
2003 4
2004 3
2005 8
2006 3
2007 12
2008 7
2009 5
2010 14
2011 12
2012 11
2013 21
2014 10
2015 16
2016 23
2017 19
2018 26
2019 24
2020 25
2021 17
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pituitary adenoma, growth hormone-secreting, 2"
Page 1
Diagnosis and Treatment of Acromegaly: An Update.
Ershadinia N, Tritos NA. Ershadinia N, et al. Mayo Clin Proc. 2022 Feb;97(2):333-346. doi: 10.1016/j.mayocp.2021.11.007. Mayo Clin Proc. 2022. PMID: 35120696 Review.
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion of insulin-like growth factor 1. ...Early diagnosis and adequate treatment are essential to mitigate excess mortality associated with …
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion …
Silent corticotroph adenomas.
Ben-Shlomo A, Cooper O. Ben-Shlomo A, et al. Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Pituitary. 2018. PMID: 29344907 Review.
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenocorticotrophic hormone (ACTH) without biochemical and clinical manifestation of hypercortisolism. ...RESULTS: Up to date findings regarding e …
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenocorticot …
Modern approach to resistant acromegaly.
Giustina A, di Filippo L, Uygur MM, Frara S. Giustina A, et al. Endocrine. 2023 May;80(2):303-307. doi: 10.1007/s12020-023-03317-7. Epub 2023 Feb 15. Endocrine. 2023. PMID: 36790521
BACKGROUND: Targets of acromegaly treatment are normalization of biochemical values, removal/reduction/stabilization of the pituitary mass, control of clinical activity and mortality with a multimodal/multidisciplinary approach. Despite significant technological and pharma …
BACKGROUND: Targets of acromegaly treatment are normalization of biochemical values, removal/reduction/stabilization of the pituitary …
Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.
Cai F, Chen S, Yu X, Zhang J, Liang W, Zhang Y, Chen Y, Chen S, Hong Y, Yan W, Wang W, Zhang J, Wu Q. Cai F, et al. Neuro Oncol. 2022 Jun 1;24(6):925-935. doi: 10.1093/neuonc/noab291. Neuro Oncol. 2022. PMID: 34932801 Free PMC article.
BACKGROUND: Clinically, the low expression of wild-type aryl hydrocarbon receptor-interacting protein (AIP) in patients with sporadic growth hormone (GH)-secreting pituitary adenoma (GHPA) is associated with a more aggressive phenotype. ...Furth …
BACKGROUND: Clinically, the low expression of wild-type aryl hydrocarbon receptor-interacting protein (AIP) in patients with sporadic gro …
Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly-A Prospective Study.
Ilie MD, Tabarin A, Vasiljevic A, Bonneville JF, Moreau-Grangé L, Schillo F, Delemer B, Barlier A, Figarella-Branger D, Bisot-Locard S, Santos A, Chanson P, Raverot G. Ilie MD, et al. J Clin Endocrinol Metab. 2022 Nov 23;107(11):2982-2991. doi: 10.1210/clinem/dgac512. J Clin Endocrinol Metab. 2022. PMID: 36136828
Finally, SST5 IRS was higher in preoperative hyperintense compared with preoperative hypointense adenomas (P = 0.04), and most sparsely granulated and most hyperintense adenomas expressed high SST5 levels. CONCLUSION: We prospectively confirm that SST2A and adenoma granula …
Finally, SST5 IRS was higher in preoperative hyperintense compared with preoperative hypointense adenomas (P = 0.04), and most sparsely gran …
Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy.
Wang Z, Guo X, Gao L, Feng C, Lian W, Deng K, Bao X, Feng M, Wang R, Xing B. Wang Z, et al. World Neurosurg. 2019 Feb;122:e1137-e1145. doi: 10.1016/j.wneu.2018.11.004. Epub 2018 Nov 14. World Neurosurg. 2019. PMID: 30447463
OBJECTIVE: To investigate the clinical characteristics of delayed remission (DR) of growth hormone (GH)-secreting pituitary adenoma after transsphenoidal adenectomy and inform follow-up treatments. ...However, the best predictor of long-t …
OBJECTIVE: To investigate the clinical characteristics of delayed remission (DR) of growth hormone (GH)-secreting pi …
Epidemiology of acromegaly.
Holdaway IM, Rajasoorya C. Holdaway IM, et al. Pituitary. 1999 Jun;2(1):29-41. doi: 10.1023/a:1009965803750. Pituitary. 1999. PMID: 11081170 Review.
Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary adenoma, and occurring with a population prevalence of 60 per million and an incidence of 3-4 per million per year. ...Su …
Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pi …
Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas.
Park YW, Kang Y, Ahn SS, Ku CR, Kim EH, Kim SH, Lee EJ, Kim SH, Lee SK. Park YW, et al. Pituitary. 2020 Dec;23(6):691-700. doi: 10.1007/s11102-020-01077-5. Pituitary. 2020. PMID: 32851505
PURPOSE: To investigate whether radiomic features from magnetic resonance image (MRI) can predict the granulation pattern of growth hormone (GH)-secreting pituitary adenoma patients. ...CONCLUSION: Radiomic features may be useful biomarke …
PURPOSE: To investigate whether radiomic features from magnetic resonance image (MRI) can predict the granulation pattern of growt …
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C, Oearsakul T. Taweesomboonyat C, et al. World Neurosurg. 2021 Feb;146:e1360-e1366. doi: 10.1016/j.wneu.2020.12.013. Epub 2020 Dec 9. World Neurosurg. 2021. PMID: 33309643
BACKGROUND: Acromegaly is a rare, chronic disorder that mostly results from growth hormone (GH)-secreting pituitary adenoma. Transsphenoidal surgery is the first-line treatment of this adenoma. This study aimed to identify factors associa …
BACKGROUND: Acromegaly is a rare, chronic disorder that mostly results from growth hormone (GH)-secreting pituitary …
Surgical Outcome of Growth Hormone-Secreting Pituitary Adenoma with Empty Sella Using a New Classification.
Wang Q, Guo X, Gao L, Wang Z, Deng K, Lian W, Wang R, Zhu H, Xing B. Wang Q, et al. World Neurosurg. 2017 Sep;105:651-658. doi: 10.1016/j.wneu.2017.06.071. Epub 2017 Jun 19. World Neurosurg. 2017. PMID: 28642181
OBJECTIVE: To investigate outcomes and identified risk factors affecting cure and intraoperative cerebrospinal fluid leak after transsphenoidal surgery using a new classification for growth hormone-secreting pituitary adenoma associated with emp …
OBJECTIVE: To investigate outcomes and identified risk factors affecting cure and intraoperative cerebrospinal fluid leak after transsphenoi …
292 results